Realising the density dividend? Changes in urban lifestyle and culture as compact developments emerge on Cape s public transport corridors

Autor: Mckenzie, Katharine

Local planning reform has facilitated the development of some higher density residential and mixed-use development on Cape Town's transport corridors, laying the basis for more efficient and sustainable lifestyles in areas of the city served by publi

Externí odkaz: http://hdl.handle.net/11427/25384

Family violence in African communities in the Western Cape : s theological-ethical assessment

Autor: Rashe, Reuben Zolile

Thesis (DTh (Systematic Theology and Ecclesiology)--Stellenbosch University, 2008.
Family violence, commonly known as domestic violence, is becoming a serious social problem – not only in the Western Cape but in the whole country. Most women a

Externí odkaz: http://hdl.handle.net/10019.1/1250

Overzicht der Tijdschriften / Revue des Revues

Autor: Cape, S., Bogaert, Iréne

Publikováno v: Revue belge de Musicologie / Belgisch Tijdschrift voor Muziekwetenschap, 1948 Jan 01. 2(1/2), 76-91.

Externí odkaz: https://www.jstor.org/stable/3686023

Recommendations on qPCR/ddPCR assay validation by GCC.

Autor: Wissel M; Eurofins Viracor BioPharma, Lenexa,Kansas, USA., Poirier M; Altasciences, Everett, Washington, USA., Satterwhite C; Charles River Laboratories, Reno, Nevada, USA., Lin J; Frontage Laboratories, Exton, Pennsylvania, USA., Islam R; Smithers, Gaithersburg, Maryland, USA., Zimmer J; Alturas Analytics, Moscow, Idaho, USA., Khadang A; Axis Clinical, Dilworth, Minnesota, USA., Zemo J; BioAgilytix, Durham, North Carolina, USA., Lester T; BioAgilytix, Durham, North Carolina, USA., Fjording M; BioAgilytix, Durham, North Carolina, USA., Hays A; BioAgilytix, Durham, North Carolina, USA., Hughes N; Biopharmaservices, Toronto, Ontario, Canada., Garofolo F; BRI - a Frontage Company, Vancouver, British Columbia, Canada., Guilbaud R; CellCarta, Montreal, Quebec, Canada., Groeber E; Charles River Laboratories, Ashland, Ohio, USA., Renfrew H; Charles River Laboratories, Shrewsbury, Massachusetts, USA., Colletti K; Charles River Laboratories, Reno, Nevada, USA., Yu M; CIRION, Montreal, Quebec, Canada., Lin J; CMIC, Hoffman Estates, Illinois, USA., Fang X; CR Medicon, Piscataway, New Jersey, USA., Shah S; Frontage Laboratories, Exton, Pennsylvania, USA., Garofolo W; GCC, Toronto, Ontario, Canada., Kar S; GCC, Toronto, Ontario, Canada., Hayes R; ICON Laboratory Services, Whitesboro, New York, USA., Pirro J; KCAS Bioanalytical & Biomarker Services, Shawnee Mission, Kansas, USA., Kane C; KCAS Bioanalytical & Biomarker Services, Shawnee Mission, Kansas, USA., Luna M; KCAS Bioanalytical & Biomarker Services, Shawnee Mission, Kansas, USA., Xu A; Keystone Bioanalytical, Lansdale, Pennsylvania, USA., Cape S; Labcorp, Madison, Wisconsin, USA., O'Dell M; Labcorp, Indianapolis, Indiana, USA., Wheller R; LGC, Ely, UK., Ritzen H; Mercodia, Uppsala, Sweden., Vance J; Nexelis - a Q2 Solutions Company, Seattle, Washington, USA., Farley E; Pharmaron, Germantown, Maryland, USA., Matys K; PPD Laboratories, Richmond, Virginia, USA., Tabler E; PPD Laboratories, Richmond, Virginia, USA., Mylott W; PPD Laboratories, Richmond, Virginia, USA., Yuan M; PPD Laboratories, Richmond, Virginia, USA., Karnik S; Pyxant Labs, Colorado Springs, Colorado, USA., Voelker T; Pyxant Labs, Salt Lake City, Utah, USA., DuBey I; Smithers, Gaithersburg, Maryland, USA., Williard C; Syneos Health, Princeton, New Jersey, USA., Shi J; WuXi AppTec, Plainsboro, New Jersey, USA., Yamashita J; WuXi AppTec, Plainsboro, New Jersey, USA.

Publikováno v: Bioanalysis [Bioanalysis] 2022 Jun; Vol. 14 (12), pp. 853-863. Date of Electronic Publication: 2022 Jun 15.

Sensitive LC-MS/MS quantification of unconjugated maytansinoid DM4 and its metabolite S-methyl-DM4 in human plasma.

Autor: Fu Y; Pharmacokinetic Sciences - Drug Disposition, Novartis Institutes for BioMedical Research, One Health Plaza, East Hanover, NJ 07936, USA., Gorityala S; Labcorp Drug Development, 3301 Kinsman Boulevard, Madison, WI 53704, USA., Li W; Pharmacokinetic Sciences - Drug Disposition, Novartis Institutes for BioMedical Research, One Health Plaza, East Hanover, NJ 07936, USA., Humphries D; Labcorp Drug Development, 3301 Kinsman Boulevard, Madison, WI 53704, USA., Ledvina A; Labcorp Drug Development, 3301 Kinsman Boulevard, Madison, WI 53704, USA., Cape S; Labcorp Drug Development, 3301 Kinsman Boulevard, Madison, WI 53704, USA., Picard F; Pharmacokinetic Sciences - Drug Disposition, Novartis Institutes for BioMedical Research, CH-4056, Basel, Switzerland.

Publikováno v: Bioanalysis [Bioanalysis] 2022 Mar; Vol. 14 (6), pp. 357-368. Date of Electronic Publication: 2022 Mar 02.